✦ LIBER ✦

Safety and pharmacokinetics of high-dose gefitinib in patients with solid tumors: results of a phase I study

✍ Scribed by Mitchell E. Gross; Lawrence Leichman; Elizabeth S. Lowe; Alan Swaisland; David B. Agus

Publisher: Springer
Year: 2011
Tongue: English
Weight: 432 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1757-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of intermittent high-dos

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

✍ Matthew G. Fury; David B. Solit; Yungpo Bernard Su; Neal Rosen; F. M. Sirotnak; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB

A phase I and pharmacokinetics study of

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors

✍ Josephia R. Muindi; Candace S. Johnson; Donald L. Trump; Renee Christy; Kristie 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 429 KB

A phase I escalating single-dose and wee

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors

✍ Kuniaki Shirao; Takayuki Yoshino; Narikazu Boku; Ken Kato; Tetsuya Hamaguchi; Hi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 342 KB

A phase I pharmacokinetics study of 9-ni

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

✍ Zhao Yan; Zhongling Zhu; Kai Li; Peng Chen; Liuchun Wang; Chun Huang; Jinhuai Xu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 209 KB

Phase I study to determine the safety an

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors

✍ David S. Hong; James L. Abbruzzese; Karla Bogaard; Yvonne Lassere; Masakazu Fuku 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

A phase I study of the safety and pharma

A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors

✍ Herbert I. Hurwitz; Roger B. Cohen; J. Patrick McGovren; Samit Hirawat; William 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 308 KB